Your browser doesn't support javascript.
loading
Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival.
Shimose, Shigeo; Iwamoto, Hideki; Tanaka, Masatoshi; Niizeki, Takashi; Shirono, Tomotake; Kajiwara, Akira; Noda, Yu; Kamachi, Naoki; Okamura, Shusuke; Nakano, Masahito; Kuromatsu, Ryoko; Kawaguchi, Takumi; Koga, Hironori; Torimura, Takuji.
Afiliação
  • Shimose S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Iwamoto H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Tanaka M; Iwamoto Internal Medical Clinic, Kitakyushu, Japan.
  • Niizeki T; Clinical Research Center, Yokokura Hospital, Miyama, Japan.
  • Shirono T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Kajiwara A; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Noda Y; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Kamachi N; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Okamura S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Nakano M; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Kuromatsu R; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Kawaguchi T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Koga H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Torimura T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Oncology ; 99(12): 756-765, 2021.
Article em En | MEDLINE | ID: mdl-34518483
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Quimioembolização Terapêutica / Carcinoma Hepatocelular / Progressão da Doença / Sorafenibe / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Quimioembolização Terapêutica / Carcinoma Hepatocelular / Progressão da Doença / Sorafenibe / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Ano de publicação: 2021 Tipo de documento: Article